Impact of Delayed Adjuvant Radiotherapy in the Survival of Women with Breast Cancer
Open Access
- 30 July 2018
- journal article
- Published by Springer Nature in Cureus
- Vol. 10 (7) , e3071
Abstract
Our objective was to determine whether a delay in adjuvant radiotherapy is related to a decrease in relapse-free survival and disease-specific survival of women with operable breast cancer. Data on 1000 patients diagnosed with breast cancer were recorded. The cohort was divided into five groups according to the timing of radiotherapy: ≤30 days, 31 to 60 days, 61 to 90 days, 91 to 120 days, and >120 days. The relapse-free survival and disease-specific survival were also calculated in relation to the number of patients. This study found no statistical difference for delays in adjuvant radiotherapy in patients with early breast cancer, but we noted a statistical decrease in disease-specific survival in patients with locally advanced breast cancer receiving radiotherapy after a delay of at least 60 days. Waiting times for radiotherapy should be as short as reasonably achievable, given the specific risk factors in the individual patient.Keywords
This publication has 24 references indexed in Scilit:
- The Effect of Waiting Times for Postoperative Radiotherapy on Outcomes for Women Receiving Partial Mastectomy for Breast Cancer: a Systematic Review and Meta-AnalysisClinical Oncology, 2016
- Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VIIInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Timing of radiotherapy following breast-conserving surgery: outcome of 1393 patients at a single institutionStrahlentherapie und Onkologie, 2014
- Timing of radiotherapy in breast-conserving therapy: a large prospective cohort study of node-negative breast cancer patients without adjuvant systemic therapyBritish Journal of Cancer, 2013
- Optimal timing for adjuvant radiation therapy in breast cancerCritical Reviews in Oncology/Hematology, 2009
- Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Five National Surgical Adjuvant Breast and Bowel Project Node-Positive Adjuvant Breast Cancer TrialsJournal of Clinical Oncology, 2006
- Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapyCancer, 2003
- Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast CancerJournal of Clinical Oncology, 2003
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerNew England Journal of Medicine, 2002
- Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrenceCancer, 1995